Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Bushinsky

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
ESC Heart Failure|January 26, 2018
Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney diseaseBertram Pitt, David A Bushinsky, Dalane W Kitzman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2019
One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidismDavid A Bushinsky, Glenn M Chertow, Sunfa Cheng, et al.
Calcified Tissue International|February 1, 2014
1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming ratsAdeline H Ng, Kevin K Frick, Nancy S Krieger, et al.
Clinical Kidney Journal|February 10, 2021
Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcificationAntonio Bellasi, Paolo Raggi, Jordi Bover, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2018
Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particlesWei Chen, Viktoriya Anokhina, Gregory Dieudonne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2005
Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming ratsAlexander J Karnauskas, Johannes P T M van Leeuwen, Gert-Jan C M van den Bemd, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 4, 2022
Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosisVandana S Mathur, David A Bushinsky, Lesley Inker, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 29, 2016
Effect of Patiromer on Urinary Ion Excretion in Healthy AdultsDavid A Bushinsky, David M Spiegel, Coleman Gross, et al.
Journal of the American Society of Nephrology : JASN|January 23, 2024
VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic AcidosisNavdeep Tangri, Vandana S Mathur, David A Bushinsky, et al.
Kidney International Reports|June 14, 2019
Diabetes Mellitus Modifies the Associations of Serum Magnesium Concentration With Arterial Calcification and Stiffness in Incident Hemodialysis PatientsWei Chen, Jessica Fitzpatrick, Jose M Monroy-Trujillo, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
ESC Heart Failure|January 26, 2018
Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney diseaseBertram Pitt, David A Bushinsky, Dalane W Kitzman, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2019
One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidismDavid A Bushinsky, Glenn M Chertow, Sunfa Cheng, et al.
Calcified Tissue International|February 1, 2014
1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming ratsAdeline H Ng, Kevin K Frick, Nancy S Krieger, et al.
Clinical Kidney Journal|February 10, 2021
Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcificationAntonio Bellasi, Paolo Raggi, Jordi Bover, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2018
Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particlesWei Chen, Viktoriya Anokhina, Gregory Dieudonne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2005
Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming ratsAlexander J Karnauskas, Johannes P T M van Leeuwen, Gert-Jan C M van den Bemd, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 4, 2022
Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosisVandana S Mathur, David A Bushinsky, Lesley Inker, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 29, 2016
Effect of Patiromer on Urinary Ion Excretion in Healthy AdultsDavid A Bushinsky, David M Spiegel, Coleman Gross, et al.
Journal of the American Society of Nephrology : JASN|January 23, 2024
VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic AcidosisNavdeep Tangri, Vandana S Mathur, David A Bushinsky, et al.
Kidney International Reports|June 14, 2019
Diabetes Mellitus Modifies the Associations of Serum Magnesium Concentration With Arterial Calcification and Stiffness in Incident Hemodialysis PatientsWei Chen, Jessica Fitzpatrick, Jose M Monroy-Trujillo, et al.
Pageof 13